A company owned by its employees and by a Foundation in a way that protects our business against surprise speculation: this is my goal to ensure its continuity.

M. Pierre Fabre


Laboratoires Pierre Fabre is majority owned by a government-recognized public-interest Foundation (by decree dated 6 April 1999): the Pierre Fabre Foundation.

In 2008, Mr. Pierre Fabre had already made a donation of the majority of his shares in the company to the Foundation. He completed this donation by appointing the Foundation as the sole legatee.  

The Foundation now holds 86% of the capital of Pierre Fabre SA, through the holding company Pierre Fabre Participations (PFP).

7.8 % of the remaining shares are held by the employees (through the employee stock ownership plan set up in 2005) and 6.2 % is held as treasury stock (shares held by the company itself).

The Foundation, a majority shareholder



The main aim of the Pierre Fabre Foundation, a government-recognized public-interest organization, is to improve access to quality medication and care in the least developed and developing countries.

  • The Pierre Fabre Foundation’s priorities lie in investing in programs concerning:The training of pharmacists and health professionals.
  • The fight against sickle-cell anemia, a serious genetic illness that mainly affects the African continent.

Since its creation in 1999, the Foundation has mainly been involved in Africa and Asia, in the following countries: Laos, Cambodia, Vietnam, Madagascar, Senegal, Mali, Benin, Guinea and Togo.

The Foundation is chaired by Mr. Pierre-Yves Revol. Its Board of Directors has 14 members, 2 of whom are representatives of the French State, and who monitor the public interest mission for which the Foundation is recognized as a public-interest organization.

Fondation Pierre Fabre


9 out of 10 employees are shareholders

Launched in France in 2005, the employee shareholder plan has been open to employees of our 9 main European subsidiaries since 2008. The total scope covered by the plan thus encompasses over 85% of the group's staff. Currently 85.3% of all employees able to benefit from the plan are shareholders. They hold 8.5% of the company's capital (2018 figures).

The plan constitutes a major element of the way in which our capital is organized. It also contributes towards the development of a new corporate culture, in which each employee is even more closely associated with the life and growth of the company. Financial information targeting employees  is proposed regularly, while training programs in the economics of the company are organized. This plan also allows employees to increase their savings: any payments made can be supplemented by the company in accordance with a matching system.


The management of employee shareholdings is carried out by the supervisory board, which is composed of 6 members representing shareholders and 6 members representing the company. Its chairman, by law a representative of the shareholders, sits on the Board of Directors of Pierre Fabre SA.
In 2012, the French Federation of Employee Share Ownership honored Pierre Fabre Laboratories with three of the six awards for employee shareholding: the Grand Prix de l'actionnariat‐salarié des sociétés non cotées (the Grand Prix of employee shareholding for unlisted companies), the Grand Prix de la qualité de l'information et de la formation des actionnaires‐salariés (the Grand Prix of information quality and training for employee shareholders), the Grand Prix des Présidents d'associations (the Grand Prix of association presidents).